Order Article Reprints

Euesden J, Gowrisankar S, Qu AX, St. Jean P, Hughes AR, Pulford DJ. Cognitive Decline in Alzheimer’s Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting. Genes. 2020; 11(5):501. https://doi.org/10.3390/genes11050501

Euesden, Jack, Sivakumar Gowrisankar, Angela Xiaoyan Qu, Pamela St. Jean, Arlene R. Hughes, and David J. Pulford. 2020. "Cognitive Decline in Alzheimer’s Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting" Genes 11, no. 5: 501. https://doi.org/10.3390/genes11050501

Euesden, J., Gowrisankar, S., Qu, A. X., St. Jean, P., Hughes, A. R., & Pulford, D. J. (2020). Cognitive Decline in Alzheimer’s Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting. Genes, 11(5), 501. https://doi.org/10.3390/genes11050501